I agree that this site is using cookies. You can find further informations here.
X
van Breeschoten, J. (Jesper)
45  results:
Search for persons X
?
1

Improving survival in advanced melanoma patients: a trend a..:

van Not, Olivier J. ; van den Eertwegh, Alfons J.M. ; Haanen, John B....
eClinicalMedicine.  69 (2024)  - p. 102485 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Population mortality in advanced melanoma patients with and..:

van Breeschoten, Jesper ; van den Eertwegh, Alfons J.M. ; Hilarius, Doranne L....
European Journal of Cancer.  182 (2023)  - p. 132-143 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Response to immune checkpoint inhibitors in acral melanoma:..:

van Not, Olivier J. ; de Meza, Melissa M. ; van den Eertwegh, Alfons J.M....
European Journal of Cancer.  167 (2022)  - p. 70-80 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1..:

van Breeschoten, Jesper ; Wouters, Michel W. J. M. ; Hilarius, Doranne L....
British Journal of Cancer.  126 (2022)  9 - p. 1362-1362 , 2022
Link: https://doi.org/10.1038/..
 
?
5

Adjuvant treatment for melanoma in clinical practice – Tria..:

de Meza, Melissa M. ; Ismail, Rawa K. ; Rauwerdink, Daan...
European Journal of Cancer.  158 (2021)  - p. 234-245 , 2021
Link: https://doi.org/10.1016/..
 
?
6

The unfavorable effects of COVID‐19 on Dutch advanced melan..:

van Not, Olivier J. ; van Breeschoten, Jesper ; van den Eertwegh, Alfonsus J. M....
International Journal of Cancer.  150 (2021)  5 - p. 816-824 , 2021
Link: https://doi.org/10.1002/..
 
?
7

Hospital Variation in Cancer Treatments and Survival OutCom..:

van Breeschoten, Jesper ; van den Eertwegh, Alfonsus J. M. ; de Wreede, Liesbeth C....
Cancers.  13 (2021)  20 - p. 5077 , 2021
Link: https://doi.org/10.3390/..
 
?
8

First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy..:

van Breeschoten, Jesper ; Wouters, Michel W. J. M. ; Hilarius, Doranne L....
British Journal of Cancer.  124 (2021)  7 - p. 1222-1230 , 2021
Link: https://doi.org/10.1038/..
 
?
9

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1..:

van Breeschoten, Jesper ; Wouters, Michel W. J. M. ; Hilarius, Doranne L....
British Journal of Cancer.  124 (2021)  10 - p. 1746-1746 , 2021
Link: https://doi.org/10.1038/..
 
?
10

An invisible group of COVID-19 victims; impact on Dutch lun..:

van Breeschoten, Jesper ; Ismail, Rawa ; Smit, Hans..
Lung Cancer.  159 (2021)  - p. 177-178 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Real-world Outcomes of Ipilimumab Plus Nivolumab Combinatio..:

van Zeijl, Michiel C T ; van Breeschoten, Jesper ; de Wreede, Liesbeth C...
https://research.rug.nl/en/publications/efed156f-7b5b-414a-a016-bf59943ddcb8.  , 2023
Link: https://hdl.handle.net/1..
 
?
12

Population mortality in advanced melanoma patients with and..:

van Breeschoten, Jesper ; van den Eertwegh, Alfons J.M ; Hilarius, Doranne L...
https://research.rug.nl/en/publications/bebd19a6-b8f2-49df-8391-ba7768c7a7a3.  , 2023
Link: https://hdl.handle.net/1..
 
?
13

End-of-Life Use of Systemic Therapy in Patients With Advanc..:

van Breeschoten, Jesper ; Ismail, Rawa K ; Wouters, Michel W J M...
https://research.rug.nl/en/publications/bb14bda4-4684-4c12-a354-71a99b420610.  , 2022
Link: https://hdl.handle.net/1..
 
?
14

Medication Use and Clinical Outcomes by the Dutch Institute..:

Rawa Kamaran Ismail ; Jesper van Breeschoten ; Silvia van der Flier...
https://www.jmir.org/2022/6/e33446.  , 2022
Link: https://doi.org/10.2196/..
 
?
15

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1..:

van Breeschoten, Jesper ; Wouters, Michel W. J. M ; Hilarius, Doranne L...
https://research.rug.nl/en/publications/8e4dbb41-36c6-43fd-860f-88d38c60034d.  , 2022
Link: https://hdl.handle.net/1..
 
1-15